SCHEMBL6407458

SCHEMBL6407458

CCCc1c(OCCCN2CCCCC2=O)ccc2c(CC(C)(C)C)onc12

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 12/20 0.41
NR1H3 Q13133 11/20 0.41
PPARA Q07869 9/20 0.37
PPARG P37231 7/20 0.37
GRM2 Q14416 1/20 0.36
PPARD Q03181 8/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PGK1 P00558 1/20 0.34
P2RY12 Q9H244 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404754 0.86 NR1H2 (0.48) NR1H2NR1H3PPARAPPARGGRM2
SCHEMBL6406097 0.85 NR1H2 (0.47) NR1H2NR1H3PPARAPPARGPPARD
SCHEMBL6405614 0.84 NR1H2 (0.47) NR1H2NR1H3PPARAPPARGPPARD
SCHEMBL6098935 0.84 GRM2 (0.52) NR1H2NR1H3PPARAPPARGGRM2
SCHEMBL6408328 0.81 NR1H2 (0.46) NR1H2NR1H3PPARAPPARGGRM2
SCHEMBL6405846 0.81 NR1H2 (0.64) NR1H2NR1H3PPARAPPARGGRM2
SCHEMBL6099203 0.78 NR1H3 (0.67) NR1H2NR1H3PPARAPPARGPPARD
SCHEMBL6102250 0.77 NR1H3 (0.66) NR1H2NR1H3PPARAPPARGPPARD
SCHEMBL6405513 0.77 NR1H2 (0.44) NR1H2NR1H3PPARAPPARGGRM2
SCHEMBL6411684 0.74 NR1H2 (0.57) NR1H2NR1H3ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534696-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS Merck & Co., Inc. (US) 2005-06-01 EP claimed
WO-2004011448-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS MERCK & CO., INC. (US) 2004-02-05 WO claimed
EP-1534696-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS Merck & Co., Inc. (US) 2005-06-01 EP disclosed
WO-2004011448-A1 THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS MERCK & CO., INC. (US) 2004-02-05 WO disclosed